Once-weekly insulin efsitora alfa versus once-daily insulin glargine U100 in adults with type 2 diabetes treated with basal and prandial insulin (QWINT-4): a phase 3, randomised, non-inferiority trial
Thomas Blevins, Dominik Dahl, Federico Pérez Manghi, Sreenivasa Murthy, Ramón Ortiz Carrasquillo, Xiaoqi Li, Annette M. Chang, Molly C. Carr, Michelle L. Katz
Topics & Concepts
Insulin glargineMedicineBasal insulinInsulinInternal medicineType 2 diabetesEndocrinologyBasal (medicine)Diabetes mellitusDiabetes Management and ResearchHyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes, Cardiovascular Risks, and Lipoproteins